The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 15, 2017

Filed:

Nov. 14, 2013
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Frank Bennett, Cranford, NJ (US);

Yuhua Huang, Westfield, NJ (US);

Lingyan Wang, East Brunswick, NJ (US);

Stephane L. Bogen, Somerset, NJ (US);

Angela D. Kerekes, Plainfield, NJ (US);

Vinay M. Girijavallabhan, Whippany, NJ (US);

Gabor Butora, Martinsville, NJ (US);

Quang Truong, Morganville, NJ (US);

Ian Davies, Princeton, NJ (US);

Ann E. Weber, Scotch Plains, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); C07H 19/10 (2006.01); A61K 45/06 (2006.01); A61K 31/7072 (2006.01); C07H 19/06 (2006.01); C07H 19/067 (2006.01); C07H 19/09 (2006.01); C07H 19/11 (2006.01); A61K 31/706 (2006.01); A61K 31/7064 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
C07H 19/10 (2013.01); A61K 31/7072 (2013.01); A61K 45/06 (2013.01); C07H 19/06 (2013.01); C07H 19/067 (2013.01); C07H 19/09 (2013.01); C07H 19/11 (2013.01); A61K 31/706 (2013.01); A61K 31/7064 (2013.01); A61K 31/7068 (2013.01);
Abstract

The present invention relates to 2'-Alkynyl Substituted Nucleoside Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein B, X, R1, R2, R3 and R4 are as defined herein. The present invention also relates to compositions comprising at least one 2′-Alkynyl Substituted Nucleoside Derivative, and methods of using the 2′-Alkynyl Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.


Find Patent Forward Citations

Loading…